BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiménez-Castro MB, Cornide-Petronio ME, Gracia-Sancho J, Peralta C. Inflammasome-Mediated Inflammation in Liver Ischemia-Reperfusion Injury. Cells 2019;8:E1131. [PMID: 31547621 DOI: 10.3390/cells8101131] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Fagenson AM, Xu K, Saaoud F, Nanayakkara G, Jhala NC, Liu L, Drummer C, Sun Y, Lau KN, Di Carlo A, Jiang X, Wang H, Karhadkar SS, Yang X. Liver Ischemia Reperfusion Injury, Enhanced by Trained Immunity, Is Attenuated in Caspase 1/Caspase 11 Double Gene Knockout Mice. Pathogens 2020;9:E879. [PMID: 33114395 DOI: 10.3390/pathogens9110879] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Wu R, Fan X, Wang Y, Shen M, Zheng Y, Zhao S, Yang L. Mesenchymal Stem Cell-Derived Extracellular Vesicles in Liver Immunity and Therapy. Front Immunol 2022;13:833878. [DOI: 10.3389/fimmu.2022.833878] [Reference Citation Analysis]
3 Zhang L, Li N, Cui LL, Xue FS, Zhu ZJ. Intraoperative Low-Dose Dexmedetomidine Administration Associated with Reduced Hepatic Ischemia-Reperfusion Injury in Pediatric Deceased Liver Transplantation: A Retrospective Cohort Study. Ann Transplant 2021;26:e933354. [PMID: 34650026 DOI: 10.12659/AOT.933354] [Reference Citation Analysis]
4 Yu Y, Zhang C, Zhang F, Liu C, Li H, Lou J, Xu Z, Liu Y, Cao J, Mi W. Development and validation of a risk nomogram for postoperative acute kidney injury in older patients undergoing liver resection: a pilot study. BMC Anesthesiol 2022;22:22. [PMID: 35026992 DOI: 10.1186/s12871-022-01566-z] [Reference Citation Analysis]
5 Ni YA, Chen H, Nie H, Zheng B, Gong Q. HMGB1: An overview of its roles in the pathogenesis of liver disease. J Leukoc Biol 2021. [PMID: 33784425 DOI: 10.1002/JLB.3MR0121-277R] [Reference Citation Analysis]
6 Vong CT, Tseng HHL, Yao P, Yu H, Wang S, Zhong Z, Wang Y. Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases. Drug Discov Today 2021;26:1394-408. [PMID: 33636340 DOI: 10.1016/j.drudis.2021.02.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Al Mamun A, Wu Y, Jia C, Munir F, Sathy KJ, Sarker T, Monalisa I, Zhou K, Xiao J. Role of pyroptosis in liver diseases. Int Immunopharmacol 2020;84:106489. [PMID: 32304992 DOI: 10.1016/j.intimp.2020.106489] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
8 Du Y, Zhong F, Cheng H, Li T, Chen Y, Tan P, Huang M, Liang T, Liu Y, Xia X, Fu W. The Dietary Supplement γ-Oryzanol Attenuates Hepatic Ischemia Reperfusion Injury via Inhibiting Endoplasmic Reticulum Stress and HMGB1/NLRP3 Inflammasome. Oxid Med Cell Longev 2021;2021:4628050. [PMID: 34512864 DOI: 10.1155/2021/4628050] [Reference Citation Analysis]
9 Barbier L, Robin A, Sindayigaya R, Ducousso H, Dujardin F, Thierry A, Hauet T, Girard JP, Pellerin L, Gombert JM, Herbelin A, Salamé E. Endogenous Interleukin-33 Acts as an Alarmin in Liver Ischemia-Reperfusion and Is Associated With Injury After Human Liver Transplantation. Front Immunol 2021;12:744927. [PMID: 34621275 DOI: 10.3389/fimmu.2021.744927] [Reference Citation Analysis]
10 Hu N, Xie XC, Liu LL, Lai WD. Aberrant methylation of UBE2Q1 promoter is associated with poor prognosis of acute-on-chronic hepatitis B pre-liver failure. Medicine (Baltimore) 2021;100:e26066. [PMID: 34032735 DOI: 10.1097/MD.0000000000026066] [Reference Citation Analysis]
11 Cienfuegos-Pecina E, Moreno-Peña DP, Torres-González L, Rodríguez-Rodríguez DR, Garza-Villarreal D, Mendoza-Hernández OH, Flores-Cantú RA, Samaniego Sáenz BA, Alarcon-Galvan G, Muñoz-Espinosa LE, Ibarra-Rivera TR, Saucedo AL, Cordero-Pérez P. Treatment with sodium (S)-2-hydroxyglutarate prevents liver injury in an ischemia-reperfusion model in female Wistar rats. PeerJ 2021;9:e12426. [PMID: 34824916 DOI: 10.7717/peerj.12426] [Reference Citation Analysis]
12 Lu T, Zhang J, Cai J, Xiao J, Sui X, Yuan X, Li R, Li Y, Yao J, Lv G, Chen X, Chen H, Zeng K, Liu Y, Chen W, Chen G, Yang Y, Zheng J, Zhang Y. Extracellular vesicles derived from mesenchymal stromal cells as nanotherapeutics for liver ischaemia–reperfusion injury by transferring mitochondria to modulate the formation of neutrophil extracellular traps'. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121486] [Reference Citation Analysis]
13 Wang F, Wang F, Li F, Wang D, Li H, He X, Zhang J. Methane attenuates lung ischemia-reperfusion injury via regulating PI3K-AKT-NFκB signaling pathway. J Recept Signal Transduct Res 2020;40:209-17. [PMID: 32079441 DOI: 10.1080/10799893.2020.1727925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Xia F, Huang Z, Ndhlovu E, Zhang M, Chen X, Zhang B, Zhu P. The effect of the number of hepatic inflow occlusion times on the prognosis of ruptured hepatocellular carcinoma patients after hepatectomy. BMC Surg 2022;22. [DOI: 10.1186/s12893-022-01537-8] [Reference Citation Analysis]
15 Jacob A, Wang Z, Yen HT, Wang P. Human adrenomedullin and its binding protein attenuate tissue injury and inflammation following hepatic ischemia reperfusion in rabbits. Heliyon 2021;7:e07845. [PMID: 34485732 DOI: 10.1016/j.heliyon.2021.e07845] [Reference Citation Analysis]
16 Dossi CG, Vargas RG, Valenzuela R, Videla LA. Beneficial effects of natural compounds on experimental liver ischemia-reperfusion injury. Food Funct 2021;12:3787-98. [PMID: 33977997 DOI: 10.1039/d1fo00289a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Jiang A, Du P, Liu Y, Pu J, Shi J, Zhang H. Metformin regulates the Th17/Treg balance by glycolysis with TIGAR in hepatic ischemia-reperfusion injury. J Pharmacol Sci 2021;146:40-8. [PMID: 33858654 DOI: 10.1016/j.jphs.2021.01.006] [Reference Citation Analysis]
18 Mardomi A, Naderi SB, Vahed SZ, Ardalan M. New insights on the monitoring of solid-organ allografts based on immune cell signatures. Transpl Immunol 2021;70:101509. [PMID: 34843937 DOI: 10.1016/j.trim.2021.101509] [Reference Citation Analysis]
19 Cao J, Xu T, Zhou C, Wang S, Jiang B, Wu K, Ma L. NR4A1 knockdown confers hepatoprotection against ischaemia-reperfusion injury by suppressing TGFβ1 via inhibition of CYR61/NF-κB in mouse hepatocytes. J Cell Mol Med 2021;25:5099-112. [PMID: 33942481 DOI: 10.1111/jcmm.16493] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Kölükçü E, Parlaktaş BS, Kölükçü V, Firat F, Deresoy FA, Katar M, Kuyucu YE, Unsal V. Protective effects of dexmedetomidine on ischaemia-reperfusion injury in an experimental rat model of priapism. Andrologia 2021;53:e13985. [PMID: 33474739 DOI: 10.1111/and.13985] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Weng J, Wang X, Xu B, Li W. Augmenter of liver regeneration ameliorates ischemia-reperfusion injury in steatotic liver via inhibition of the TLR4/NF-κB pathway. Exp Ther Med 2021;22:863. [PMID: 34178136 DOI: 10.3892/etm.2021.10295] [Reference Citation Analysis]
22 Alkattan W, Yaqinuddin A, Shafqat A, Kashir J. NET-Mediated Pathogenesis of COVID-19: The Role of NETs in Hepatic Manifestations. Journal of Health and Allied Sciences NU. [DOI: 10.1055/s-0041-1741418] [Reference Citation Analysis]
23 Al Mamun A, Akter A, Hossain S, Sarker T, Safa SA, Mustafa QG, Muhammad SA, Munir F. Role of NLRP3 inflammasome in liver disease. J Dig Dis 2020;21:430-6. [PMID: 32585073 DOI: 10.1111/1751-2980.12918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Krawczyk P, Morawski M, Krasnodębski M, Sieńko D, Grąt M, Kron P, Lodge P. Long-Term Effects of Pedicle Clamping during Major Hepatectomy for Colorectal Liver Metastases. J Clin Med 2021;10:2778. [PMID: 34202824 DOI: 10.3390/jcm10132778] [Reference Citation Analysis]
25 Guo H, Ni M, Xu J, Chen F, Yao Z, Yao Y, Liu C, Du Q. Transcriptional enhancement of GBP-5 by BATF aggravates sepsis-associated liver injury via NLRP3 inflammasome activation. FASEB J 2021;35:e21672. [PMID: 34042221 DOI: 10.1096/fj.202100234R] [Reference Citation Analysis]
26 Cheng Z, Guo C. Pemafibrate Pretreatment Attenuates Apoptosis and Autophagy during Hepatic Ischemia-Reperfusion Injury by Modulating JAK2/STAT3β/PPARα Pathway. PPAR Res 2021;2021:6632137. [PMID: 33777128 DOI: 10.1155/2021/6632137] [Reference Citation Analysis]
27 Wang M, Zhang J, Zhang J, Sun K, Li Q, Kuang B, Wang MMZ, Hou S, Gong N. Methyl eugenol attenuates liver ischemia reperfusion injury via activating PI3K/Akt signaling. Int Immunopharmacol 2021;99:108023. [PMID: 34358859 DOI: 10.1016/j.intimp.2021.108023] [Reference Citation Analysis]
28 Li S, Zhu J, Pan L, Wan P, Qin Q, Luo D, Pan W, Wei Y, Xu Y, Shang L, Ye X. Potential protective effect of hesperidin on hypoxia/reoxygenation-induced hepatocyte injury. Exp Ther Med 2021;22:764. [PMID: 34035861 DOI: 10.3892/etm.2021.10196] [Reference Citation Analysis]
29 Chaves Cayuela N, Kiyomi Koike M, Jacysyn JF, Rasslan R, Azevedo Cerqueira AR, Pereira Costa SK, Picanço Diniz-Júnior JA, Massazo Utiyama E, Frasson de Souza Montero E. N-Acetylcysteine Reduced Ischemia and Reperfusion Damage Associated with Steatohepatitis in Mice. Int J Mol Sci 2020;21:E4106. [PMID: 32526845 DOI: 10.3390/ijms21114106] [Reference Citation Analysis]
30 Micó-Carnero M, Rojano-Alfonso C, Álvarez-Mercado AI, Gracia-Sancho J, Casillas-Ramírez A, Peralta C. Effects of Gut Metabolites and Microbiota in Healthy and Marginal Livers Submitted to Surgery. Int J Mol Sci 2020;22:E44. [PMID: 33375200 DOI: 10.3390/ijms22010044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
31 Zhang Y, Pan Q, Liu Y. CXCL16 silencing alleviates hepatic ischemia reperfusion injury during liver transplantation by inhibiting p38 phosphorylation. Pathology - Research and Practice 2020;216:152913. [DOI: 10.1016/j.prp.2020.152913] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Ding Y, Zhang Y, Zhang W, Shang J, Xie Z, Chen C. Effects of Lipoic Acid on Ischemia-Reperfusion Injury. Oxid Med Cell Longev 2021;2021:5093216. [PMID: 34650663 DOI: 10.1155/2021/5093216] [Reference Citation Analysis]
33 Schmitz SM, Dohmeier H, Stoppe C, Alizai PH, Schipper S, Neumann UP, Coburn M, Ulmer TF. Inhaled Argon Impedes Hepatic Regeneration after Ischemia/Reperfusion Injury in Rats. Int J Mol Sci 2020;21:E5457. [PMID: 32751707 DOI: 10.3390/ijms21155457] [Reference Citation Analysis]
34 Li H, Shen X, Tong Y, Ji T, Feng Y, Tang Y, Mai R, Ye J, Que T, Luo X. Aggravation of hepatic ischemia‑reperfusion injury with increased inflammatory cell infiltration is associated with the TGF‑β/Smad3 signaling pathway. Mol Med Rep 2021;24:580. [PMID: 34132369 DOI: 10.3892/mmr.2021.12219] [Reference Citation Analysis]
35 Cai J, Zhang X, Chen P, Li Y, Liu S, Liu Q, Zhang H, Wu Z, Song K, Liu J, Shan B, Liu Y. The ER stress sensor inositol-requiring enzyme 1α in Kupffer cells promotes hepatic ischemia-reperfusion injury. J Biol Chem 2021;:101532. [PMID: 34953853 DOI: 10.1016/j.jbc.2021.101532] [Reference Citation Analysis]
36 Trujillo-rangel WÁ, García-valdés L, Méndez-del Villar M, Castañeda-arellano R, Totsuka-sutto SE, García-benavides L, Cabello-verrugio C. Therapeutic Targets for Regulating Oxidative Damage Induced by Ischemia-Reperfusion Injury: A Study from a Pharmacological Perspective. Oxidative Medicine and Cellular Longevity 2022;2022:1-25. [DOI: 10.1155/2022/8624318] [Reference Citation Analysis]
37 Li F, Zhang L, Xue H, Xuan J, Rong S, Wang K. SIRT1 alleviates hepatic ischemia-reperfusion injury via the miR-182-mediated XBP1/NLRP3 pathway. Mol Ther Nucleic Acids 2021;23:1066-77. [PMID: 33664991 DOI: 10.1016/j.omtn.2020.11.015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Ye L, He S, Mao X, Zhang Y, Cai Y, Li S. Effect of Hepatic Macrophage Polarization and Apoptosis on Liver Ischemia and Reperfusion Injury During Liver Transplantation. Front Immunol 2020;11:1193. [PMID: 32676077 DOI: 10.3389/fimmu.2020.01193] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
39 Wen H, He R, Wang H, Zhao S, Zheng J, Wu J, Xie M. Effects of small molecule inhibitor SW033291 on hepatic ischemia-reperfusion injury in mice. Biochemical and Biophysical Research Communications 2022;615:70-4. [DOI: 10.1016/j.bbrc.2022.05.049] [Reference Citation Analysis]
40 Knijff LWD, van Kooten C, Ploeg RJ. The Effect of Hypothermic Machine Perfusion to Ameliorate Ischemia-Reperfusion Injury in Donor Organs. Front Immunol 2022;13:848352. [DOI: 10.3389/fimmu.2022.848352] [Reference Citation Analysis]
41 Chen SY, Zhang HP, Li J, Shi JH, Tang HW, Zhang Y, Zhang JK, Wen PH, Wang ZH, Shi XY, He YT, Hu BW, Yang H, Guo WZ, Zhang SJ. Tripartite Motif-Containing 27 Attenuates Liver Ischemia/Reperfusion Injury by Suppressing Transforming Growth Factor β-Activated Kinase 1 (TAK1) by TAK1 Binding Protein 2/3 Degradation. Hepatology 2021;73:738-58. [PMID: 32343849 DOI: 10.1002/hep.31295] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
42 Zhang S, Feng Z, Gao W, Duan Y, Fan G, Geng X, Wu B, Li K, Liu K, Peng C. Aucubin Attenuates Liver Ischemia-Reperfusion Injury by Inhibiting the HMGB1/TLR-4/NF-κB Signaling Pathway, Oxidative Stress, and Apoptosis. Front Pharmacol 2020;11:544124. [PMID: 33013386 DOI: 10.3389/fphar.2020.544124] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
43 Masior Ł, Grąt M. Methods of Attenuating Ischemia-Reperfusion Injury in Liver Transplantation for Hepatocellular Carcinoma. Int J Mol Sci 2021;22:8229. [PMID: 34360995 DOI: 10.3390/ijms22158229] [Reference Citation Analysis]
44 Wu K, Tao G, Xu T, An Y, Yu X, Wang Y, Wang S, Guo W, Ma L. Downregulation of miR-497-5p prevents liver ischemia-reperfusion injury in association with MED1/TIMP-2 axis and the NF-κB pathway. FASEB J 2021;35:e21180. [PMID: 33715222 DOI: 10.1096/fj.202001029R] [Reference Citation Analysis]
45 Pan J, Chen S, Guo W, Cao S, Shi X, Zhang J, Zhang H, Zhang S. Alpinetin protects against hepatic ischemia/reperfusion injury in mice by inhibiting the NF-κB/MAPK signaling pathways. Int Immunopharmacol 2021;95:107527. [PMID: 33743314 DOI: 10.1016/j.intimp.2021.107527] [Reference Citation Analysis]
46 Duez H, Pourcet B. Nuclear Receptors in the Control of the NLRP3 Inflammasome Pathway. Front Endocrinol (Lausanne) 2021;12:630536. [PMID: 33716981 DOI: 10.3389/fendo.2021.630536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
47 Wu Y, Qiu G, Zhang H, Zhu L, Cheng G, Wang Y, Li Y, Wu W. Dexmedetomidine alleviates hepatic ischaemia-reperfusion injury via the PI3K/AKT/Nrf2-NLRP3 pathway. J Cell Mol Med 2021;25:9983-94. [PMID: 34664412 DOI: 10.1111/jcmm.16871] [Reference Citation Analysis]
48 Ji J, Wu L, Feng J, Mo W, Wu J, Yu Q, Li S, Zhang J, Dai W, Xu X, Mao Y, Xu S, Chen K, Li J, Guo C. Cafestol preconditioning attenuates apoptosis and autophagy during hepatic ischemia-reperfusion injury by inhibiting ERK/PPARγ pathway. Int Immunopharmacol 2020;84:106529. [PMID: 32344356 DOI: 10.1016/j.intimp.2020.106529] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
49 Mou T, Luo Y, Huang Z, Zheng D, Pu X, Shen A, Pu J, Li T, Dai J, Chen W, Wu Z. Inhibition of microRNA-128-3p alleviates liver ischaemia-reperfusion injury in mice through repressing the Rnd3/NF-κB axis. Innate Immun 2020;26:528-36. [PMID: 32486927 DOI: 10.1177/1753425920928449] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
50 Zhang W, Miao R, Tang J, Su Q, Li P, Pi H. Low temperature exerts protective effects by inhibiting mitochondria-mediated apoptosis pathway following pressure injury to rat muscle. Rev Esc Enferm USP 2021;55:e20200319. [PMID: 34528993 DOI: 10.1590/1980-220X-REEUSP-2020-0319] [Reference Citation Analysis]
51 Tang D, Fu G, Li W, Sun P, Loughran PA, Deng M, Scott MJ, Billiar TR. Maresin 1 protects the liver against ischemia/reperfusion injury via the ALXR/Akt signaling pathway. Mol Med 2021;27:18. [PMID: 33632134 DOI: 10.1186/s10020-021-00280-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 El-Sisi AEE, Sokar SS, Shebl AM, Mohamed DZ, Abu-Risha SE. Octreotide and melatonin alleviate inflammasome-induced pyroptosis through inhibition of TLR4-NF-κB-NLRP3 pathway in hepatic ischemia/reperfusion injury. Toxicol Appl Pharmacol 2021;410:115340. [PMID: 33264646 DOI: 10.1016/j.taap.2020.115340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]